Science Explorer Interactive view Map
Company · Leiden · Netherlands

ISA Pharmaceuticals (Netherlands)

isa-pharma.comROR OpenAlex
Research works
38
▼ 45% vs 2013–17
Citations
3.9k
101.6 per fractional work
Top-10% rate
19.8%
record average 16.5%
Open access
56%
world 28%

Not ranked overall: ISA Pharmaceuticals (Netherlands) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.10× its world share, 0 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 1.74× its world share, 0 worksBiochemistry, Geneti…Immunology and Microbiology: 33.97× its world share, 2 worksImmunology and Micro…Neuroscience: 2.73× its world share, 0 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 1.40× its world share, 0 worksPharmacology, Toxico…Chemistry: 0.31× its world share, 0 worksChemistryEngineering: 0.02× its world share, 0 worksEngineeringEnvironmental Science: 0.30× its world share, 0 worksEnvironmental ScienceMedicine: 2.52× its world share, 3 worksMedicineEconomics, Econometrics and Finance: 0.12× its world share, 0 worksEconomics, Econometr…Social Sciences: 0.02× its world share, 0 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 34.0×. Every wedge is a field page.

Which keywords describe research at ISA Pharmaceuticals (Netherlands)?

By fractional works in all years, weighted toward what it does more of than the world: Antigen Presentation, Cancer Immunotherapy, Immunity, Dendritic Cells, Innate Immunity, Tumor Antigen, Vaccine Adjuvants and Tumor Microenvironment.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 37 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 37 words, with their numbers
  1. Antigen Presentation12▲ 303×2 topics
  2. Cancer Immunotherapy11▲ 197×2 topics
  3. Immunity10▲ 81×6 topics
  4. Dendritic Cells9▲ 212×2 topics
  5. Innate Immunity9▲ 69×2 topics
  6. Tumor Antigen9▲ 293×1 topic
  7. Vaccine Adjuvants9▲ 293×1 topic
  8. Tumor Microenvironment5▲ 40×4 topics
  9. Immune Checkpoint Blockade5▲ 233×1 topic
  10. PD-1 and PD-L15▲ 233×1 topic
  11. Epidemiology4▲ 2.8×13 topics
  12. Global Burden3▲ 15×2 topics
  13. Cancer Incidence3▲ 54×2 topics
  14. Human Papillomavirus3▲ 59×3 topics
  15. Inflammation3▲ 3.1×8 topics
  16. Viral Oncoproteins3▲ 101×2 topics
  17. Immunotherapy3▲ 11×8 topics
  18. Cervical Cancer3▲ 69×2 topics
  19. Epitope Prediction2▲ 344×1 topic
  20. Peptide-MHC Binding2▲ 344×1 topic
  21. Cytology Screening2▲ 125×1 topic
  22. HPV Vaccination2▲ 125×1 topic
  23. Leukemia2▲ 78×2 topics
  24. Lymphoma2▲ 34×2 topics
  25. Immune Response2▲ 7.6×10 topics
  26. NK Cell Recognition2▲ 47×1 topic
  27. Natural Killer Cells2▲ 47×1 topic
  28. Cancer2▲ 3.0×11 topics
  29. Tumor Regression2▲ 46×2 topics
  30. CAR T Cells1▲ 87×1 topic
  31. Chimeric Antigen Receptor1▲ 87×1 topic
  32. Pattern Recognition Receptors1▲ 23×1 topic
  33. Toll-like Receptors1▲ 20×1 topic
  34. Immunosuppression1▲ 26×3 topics
  35. Autoimmunity1▲ 14×2 topics
  36. Metabolism1▲ 4.4×2 topics
  37. Antiviral Therapy1▲ 18×3 topics

Which research topics does ISA Pharmaceuticals (Netherlands) publish most on?

By volume in 2022–2025: Immunotherapy and Immune Responses, Cancer Immunotherapy and Biomarkers, Cervical Cancer and HPV Research and vaccines and immunoinformatics approaches.

Immunotherapy and Immune…1Immunotherapy and Immune Responses: 1 fractional worksCancer Immunotherapy and…1Cancer Immunotherapy and Biomarkers: 1 fractional worksCervical Cancer and HPV …0Cervical Cancer and HPV Research: 0 fractional worksvaccines and immunoinformatics approaches: 0 fractional worksImmune Cell Function and Interaction: 0 fractional worksViral-associated cancers and disorders: 0 fractional worksIntensive Care Unit Cognitive Disorders: 0 fractional worksAnesthesia and Neurotoxicity Research: 0 fractional worksT-cell and Retrovirus Studies: 0 fractional worksImmune cells in cancer0Immune cells in cancer: 0 fractional works
ImmunologyOncologyEpidemiologyMolecular Biology2 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Immunotherapy and Immune Responses Immunology 1 works
  2. 2 Cancer Immunotherapy and Biomarkers Oncology 1 works
  3. 3 Cervical Cancer and HPV Research Epidemiology 0 works
  4. 4 vaccines and immunoinformatics approaches Molecular Biology 0 works
  5. 5 Immune Cell Function and Interaction Immunology 0 works
  6. 6 Viral-associated cancers and disorders Oncology 0 works
  7. 7 Intensive Care Unit Cognitive Disorders Critical Care and Intensive Care Medicine 0 works
  8. 8 Anesthesia and Neurotoxicity Research Developmental Neuroscience 0 works
  9. 9 T-cell and Retrovirus Studies Immunology 0 works
  10. 10 Immune cells in cancer Immunology 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available56.4%not open43.6%

World: 28% of research is openly available.

with international co-authors25.6%domestic only74.4%

World: 19% is written across borders.

How has ISA Pharmaceuticals (Netherlands)'s research output changed?

Output in 2018–2022 was 45% lower than in 2013–2017.

20002005201020152020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Leiden

All research institutions in Leiden

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.